Hence then, the article about cumberland pharmaceuticals receives fda orphan drug and rare pediatric disease designations for new treatment of duchenne muscular dystrophy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( CUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY )
Last updated :
Also on site :
- Heavy police presence in NW suburb with roads blocked due to ‘isolated incident'
- The top pandemic threats as WHO declares Ebola emergency
- Starbucks Expands Its Summer Menu With 2 Vibrant New Drinks